PART 2 of EVDAS-related expectations from MAHs
UPDATE on the discussions taking place during pilot phase
14 June 2018 – 15.00 GMT, 16.00 CEST, 10.00 EDT
with Dr Cvijeta Bielen, Medical Director
Dedicated to providing Pharmacovigilance services for over 10 years, we cover the entire product life cycle to better assists client with the effective management of their drug safety information.
PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing medical information.
In partnership with our clients, PrimeVigilance is committed to improving patient health.
Our success begins with our people. Build your career in one of the most rewarding fields in the world.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)